Correlation Between Artelo Biosciences and Crinetics Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Artelo Biosciences and Crinetics Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Artelo Biosciences and Crinetics Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Artelo Biosciences and Crinetics Pharmaceuticals, you can compare the effects of market volatilities on Artelo Biosciences and Crinetics Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Artelo Biosciences with a short position of Crinetics Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Artelo Biosciences and Crinetics Pharmaceuticals.

Diversification Opportunities for Artelo Biosciences and Crinetics Pharmaceuticals

-0.54

Correlation Coefficient

Artelo Biosciences  Crinetics Pharmaceuticals

Excellent diversification

The 3 months correlation between Artelo and Crinetics is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Artelo Biosciences and Crinetics Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crinetics Pharmaceuticals and Artelo Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Artelo Biosciences are associated (or correlated) with Crinetics Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crinetics Pharmaceuticals has no effect on the direction of Artelo Biosciences i.e., Artelo Biosciences and Crinetics Pharmaceuticals go up and down completely randomly.

Pair Corralation between Artelo Biosciences and Crinetics Pharmaceuticals

Given the investment horizon of 90 days Artelo Biosciences is expected to generate 1.13 times more return on investment than Crinetics Pharmaceuticals. However, Artelo Biosciences is 1.13 times more volatile than Crinetics Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Crinetics Pharmaceuticals is currently generating about -0.23 per unit of risk. If you would invest  107.00  in Artelo Biosciences on December 1, 2024 and sell it today you would earn a total of  0.00  from holding Artelo Biosciences or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Artelo Biosciences  vs.  Crinetics Pharmaceuticals

Artelo Biosciences

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Artelo Biosciences are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Artelo Biosciences is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.

Crinetics Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Crinetics Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Artelo Biosciences and Crinetics Pharmaceuticals

The main advantage of trading using opposite Artelo Biosciences and Crinetics Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Artelo Biosciences position performs unexpectedly, Crinetics Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crinetics Pharmaceuticals will offset losses from the drop in Crinetics Pharmaceuticals' long position.

The idea behind Artelo Biosciences and Crinetics Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.